These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 20231095)
1. Design, synthesis and in vitro/in vivo evaluation of orally bioavailable prodrugs of a catechol-O-methyltransferase inhibitor. Rautio J; Leppänen J; Lehtonen M; Laine K; Koskinen M; Pystynen J; Savolainen J; Sairanen M Bioorg Med Chem Lett; 2010 Apr; 20(8):2614-6. PubMed ID: 20231095 [TBL] [Abstract][Full Text] [Related]
2. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage. Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, ADME properties, and pharmacological activities of β-alanyl-D-histidine (D-carnosine) prodrugs with improved bioavailability. Orioli M; Vistoli G; Regazzoni L; Pedretti A; Lapolla A; Rossoni G; Canevotti R; Gamberoni L; Previtali M; Carini M; Aldini G ChemMedChem; 2011 Jul; 6(7):1269-82. PubMed ID: 21634010 [TBL] [Abstract][Full Text] [Related]
4. Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes. Dang Q; Kasibhatla SR; Reddy KR; Jiang T; Reddy MR; Potter SC; Fujitaki JM; van Poelje PD; Huang J; Lipscomb WN; Erion MD J Am Chem Soc; 2007 Dec; 129(50):15491-502. PubMed ID: 18041834 [TBL] [Abstract][Full Text] [Related]
5. The first bioreversible prodrug of metformin with improved lipophilicity and enhanced intestinal absorption. Huttunen KM; Mannila A; Laine K; Kemppainen E; Leppänen J; Vepsäläinen J; Järvinen T; Rautio J J Med Chem; 2009 Jul; 52(14):4142-8. PubMed ID: 19522462 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro/in vivo evaluation of novel oral N-alkyl- and N,N-dialkyl-carbamate esters of entacapone. Savolainen J; Leppanen J; Forsberg M; Taipale H; Nevalainen T; Huuskonen J; Gynther J; Mannisto PT; Jarvinen T Life Sci; 2000; 67(2):205-16. PubMed ID: 10901288 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of novel prodrugs of caspase inhibitors. Charrier JD; Durrant SJ; Studley J; Lawes L; Weber P Bioorg Med Chem Lett; 2012 Jan; 22(1):485-8. PubMed ID: 22104150 [TBL] [Abstract][Full Text] [Related]
8. Crystal structures of rat catechol-O-methyltransferase complexed with coumarine-based inhibitor. Tsuji E; Okazaki K; Takeda K Biochem Biophys Res Commun; 2009 Jan; 378(3):494-7. PubMed ID: 19056347 [TBL] [Abstract][Full Text] [Related]
9. Prodrug thiamine analogs as inhibitors of the enzyme transketolase. Le Huerou Y; Gunawardana I; Thomas AA; Boyd SA; de Meese J; Dewolf W; Gonzales SS; Han M; Hayter L; Kaplan T; Lemieux C; Lee P; Pheneger J; Poch G; Romoff TT; Sullivan F; Weiler S; Wright SK; Lin J Bioorg Med Chem Lett; 2008 Jan; 18(2):505-8. PubMed ID: 18083562 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and in-vitro/in-vivo evaluation of orally administered entacapone prodrugs. Leppänen J; Savolainen J; Nevalainen T; Forsberg M; Huuskonen J; Taipale H; Gynther J; Männistö PT; Järvinen T J Pharm Pharmacol; 2001 Nov; 53(11):1489-98. PubMed ID: 11732751 [TBL] [Abstract][Full Text] [Related]
11. Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability. Yan L; Müller CE J Med Chem; 2004 Feb; 47(4):1031-43. PubMed ID: 14761205 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and bioavailability evaluation of coumarin-based prodrug of meptazinol. Xie Q; Wang X; Wang X; Jiang Z; Qiu Z Bioorg Med Chem Lett; 2005 Nov; 15(22):4953-6. PubMed ID: 16154745 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro evaluation of two progressive series of bifunctional polyhydroxybenzamide catechol-O-methyltransferase inhibitors. Brevitt SE; Tan EW J Med Chem; 1997 Jun; 40(13):2035-9. PubMed ID: 9207944 [TBL] [Abstract][Full Text] [Related]
16. Chlorzoxazone esters of some non-steroidal anti-inflammatory (NSAI) carboxylic acids as mutual prodrugs: design, synthesis, pharmacological investigations and docking studies. Abdel-Azeem AZ; Abdel-Hafez AA; El-Karamany GS; Farag HH Bioorg Med Chem; 2009 May; 17(10):3665-70. PubMed ID: 19398345 [TBL] [Abstract][Full Text] [Related]
17. Bisubstrate inhibitors of the enzyme catechol O-methyltransferase (COMT): efficient inhibition despite the lack of a nitro group. Paulini R; Lerner C; Jakob-Roetne R; Zürcher G; Borroni E; Diederich F Chembiochem; 2004 Sep; 5(9):1270-4. PubMed ID: 15368579 [No Abstract] [Full Text] [Related]
18. ATP-Citrate lyase as a target for hypolipidemic intervention. 2. Synthesis and evaluation of (3R,5S)-omega-substituted-3-carboxy-3, 5-dihydroxyalkanoic acids and their gamma-lactone prodrugs as inhibitors of the enzyme in vitro and in vivo. Gribble AD; Ife RJ; Shaw A; McNair D; Novelli CE; Bakewell S; Shah VP; Dolle RE; Groot PH; Pearce N; Yates J; Tew D; Boyd H; Ashman S; Eggleston DS; Haltiwanger RC; Okafo G J Med Chem; 1998 Sep; 41(19):3582-95. PubMed ID: 9733484 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, transport and pharmacokinetics of 5'-amino acid ester prodrugs of 1-beta-D-arabinofuranosylcytosine. Sun Y; Sun J; Shi S; Jing Y; Yin S; Chen Y; Li G; Xu Y; He Z Mol Pharm; 2009; 6(1):315-25. PubMed ID: 19115956 [TBL] [Abstract][Full Text] [Related]
20. Regulation of catechol O-methyltransferase expression in granulosa cells: a potential role for follicular arrest in polycystic ovary syndrome. Salih SM; Jamaluddin M; Salama SA; Fadl AA; Nagamani M; Al-Hendy A Fertil Steril; 2008 May; 89(5 Suppl):1414-21. PubMed ID: 17612537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]